$LIDR
AEye, Inc. Stock $lidr

$lidr Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000181864422000008 Filed on March 28, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$1.804M	$3.007M	$279.0K
YoY Change	546.59%	90.44%
Cost Of Revenue	$2.100M	$3.637M	$344.0K
YoY Change	510.47%	350.12%
Gross Profit	-$296.0K	-$630.0K	-$65.00K
YoY Change	355.38%	-181.71%
Gross Profit Margin	-16.41%	-20.95%	-23.3%
Selling, General & Admin	$15.73M	$36.06M	$2.651M
YoY Change	493.25%	256.24%
% of Gross Profit
Research & Development	$7.513M	$26.54M	$5.920M
YoY Change	26.91%	54.95%
% of Gross Profit
Depreciation & Amortization	$245.0K	$1.014M	$243.0K
YoY Change	0.82%	9.98%
% of Gross Profit
Operating Expenses	$23.24M	$62.61M	$8.574M
YoY Change	171.05%	129.72%
Operating Profit	-$23.54M	-$63.24M	-$8.639M
YoY Change	172.44%	138.78%
Interest Expense	-$1.498M	-$4.073M	-$417.0K
YoY Change	259.23%	5802.9%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$1.776M
YoY Change		2473.91%
Pretax Income	-$25.03M	-$65.01M	-$9.056M
YoY Change	176.44%	144.85%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$25.03M	-$65.01M	-$9.056M
YoY Change	176.44%	144.85%
Net Earnings / Revenue	-1387.69%	-2161.99%	-3245.88%
Basic Earnings Per Share		-$0.60
Diluted Earnings Per Share	-$150.7K	-$0.60	-$54.51K
COMMON SHARES
Basic Shares Outstanding	154.6M shares	109.1M shares
Diluted Shares Outstanding		109.1M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$164.0M	$164.0M	$15.28M
YoY Change	973.7%	973.7%
Cash & Equivalents	$14.18M	$14.18M	$15.28M
Short-Term Investments	$149.8M	$149.8M	$0.00
Other Short-Term Assets	$102.0K	$5.051M	$847.0K
YoY Change	-87.96%	461.22%
Inventory	$4.085M	$4.085M	$2.655M
Prepaid Expenses	$3.980M		$549.0K
Receivables	$4.222M	$4.222M	$156.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$177.4M	$177.4M	$19.48M
YoY Change	810.4%	810.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.129M	$5.129M	$4.865M
YoY Change	5.43%	5.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.509M	$3.659M	$315.0K
YoY Change	379.05%	137.91%
Total Long-Term Assets	$8.788M	$8.788M	$6.403M
YoY Change	37.25%	37.25%
TOTAL ASSETS
Total Short-Term Assets	$177.4M	$177.4M	$19.48M
Total Long-Term Assets	$8.788M	$8.788M	$6.403M
Total Assets	$186.2M	$186.2M	$25.89M
YoY Change	619.15%	619.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.542M	$2.542M	$1.807M
YoY Change	40.68%	40.68%
Accrued Expenses	$8.739M	$7.192M	$3.356M
YoY Change	160.4%	119.67%
Deferred Revenue	$2.287M		$660.0K
YoY Change	246.52%
Short-Term Debt	$0.00	$0.00	$29.08M
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$0.00	$0.00	$2.693M
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$13.57M	$13.57M	$37.60M
YoY Change	-63.91%	-63.91%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$2.884M
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$786.0K	$3.818M	$0.00
YoY Change		5.15%
Total Long-Term Liabilities	$786.0K	$3.818M	$2.884M
YoY Change	-72.75%	-41.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.57M	$13.57M	$37.60M
Total Long-Term Liabilities	$786.0K	$3.818M	$2.884M
Total Liabilities	$17.39M	$17.39M	$44.11M
YoY Change	-60.58%	-60.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$151.8M		-$86.78M
YoY Change	74.91%
Common Stock	$16.00K		$10.00K
YoY Change	60.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$168.8M	$168.8M	-$18.23M
YoY Change
Total Liabilities & Shareholders Equity	$186.2M	$186.2M	$25.89M
YoY Change	619.15%	619.15%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$25.03M	-$65.01M	-$9.056M
YoY Change	176.44%	144.85%
Depreciation, Depletion And Amortization	$245.0K	$1.014M	$243.0K
YoY Change	0.82%	9.98%
Cash From Operating Activities	-$16.12M	-$55.70M	-$5.731M
YoY Change	181.19%	182.91%
INVESTING ACTIVITIES
Capital Expenditures	-$308.0K	$1.021M	-$19.00K
YoY Change	1521.05%	-74.7%
Acquisitions
YoY Change
Other Investing Activities	-$20.53M	-$150.5M	$0.00
YoY Change
Cash From Investing Activities	-$20.83M	-$151.5M	-$19.00K
YoY Change	109552.63%	3654.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$13.33M
YoY Change		1898.95%
Cash From Financing Activities	-1.337M	$207.1M	17.59M
YoY Change	-107.6%	546.77%
NET CHANGE
Cash From Operating Activities	-16.12M	-$55.70M	-5.731M
Cash From Investing Activities	-20.83M	-$151.5M	-19.00K
Cash From Financing Activities	-1.337M	$207.1M	17.59M
Net Change In Cash	-38.29M	-$165.0K	11.84M
YoY Change	-423.36%	-101.99%
FREE CASH FLOW
Cash From Operating Activities	-$16.12M	-$55.70M	-$5.731M
Capital Expenditures	-$308.0K	$1.021M	-$19.00K
Free Cash Flow	-$15.81M	-$56.72M	-$5.712M
YoY Change	176.73%	139.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001818644
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	333-259554
CY2021	dei	Entity Registrant Name EntityRegistrantName	AEye, Inc.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1827430
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Park Place
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Dublin
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94568
CY2021	dei	City Area Code CityAreaCode	(925)
CY2021	dei	Local Phone Number LocalPhoneNumber	400-4366
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2021	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	574124207	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	156333865	shares
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	San Francisco, California
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14183000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15275000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	149824000	USD
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	0	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4222000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	156000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4085000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	2655000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5051000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1396000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	177365000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	19482000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5129000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4865000	USD
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2150000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1223000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1509000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	315000	USD
CY2021Q4	us-gaap	Assets Assets	186153000	USD
CY2020Q4	us-gaap	Assets Assets	25885000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2542000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1807000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8739000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3356000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2287000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	660000	USD
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0	USD
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	29079000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2693000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13568000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37595000	USD
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3032000	USD
CY2020Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	3631000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2884000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	786000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2021Q4	us-gaap	Liabilities Liabilities	17386000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	44110000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155137237	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155137237	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101286645	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101286645	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	10000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	168767000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	320937000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68549000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-391000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-151795000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-86784000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-18225000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	186153000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	25885000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3007000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1579000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	3637000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	808000	USD
CY2021	us-gaap	Gross Profit GrossProfit	-630000	USD
CY2020	us-gaap	Gross Profit GrossProfit	771000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	27253000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-63235000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26543000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17130000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10548000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3408000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25514000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6715000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	62605000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-26482000	USD
CY2021	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	223000	USD
CY2020	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	1410000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2297000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	561000	USD
CY2020	us-gaap	Interest And Other Income InterestAndOtherIncome	23000	USD
CY2020	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	1410000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2297000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	10018000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1952000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	725000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	97000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	752000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	830000	USD
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-310000	USD
CY2020	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-287000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-68000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4066000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2633000	USD
CY2021	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	4857000	USD
CY2020	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	1502000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1776000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-69000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-65011000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-26551000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-391000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-65402000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-26551000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10018000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	150000	USD
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109055894	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109055894	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102803202	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102803202	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-18225000	USD
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	39095000	USD
CY2021	lidr	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	256811000	USD
CY2021	lidr	Adjustments To Additional Paid In Capital Reverse Recapitalization Transaction Costs AdjustmentsToAdditionalPaidInCapitalReverseRecapitalizationTransactionCosts	52661000	USD
CY2021	lidr	Adjustments To Additional Paid In Capital Assumption Of Warrant Liability AdjustmentsToAdditionalPaidInCapitalAssumptionOfWarrantLiability	268000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1583000	USD
CY2021	lidr	Apic Share Based Payment Arrangement Option Decrease For Repurchase APICShareBasedPaymentArrangementOptionDecreaseForRepurchase	1500000	USD
CY2021	lidr	Stock Issued During Period Value Restricted Stock Units Vested StockIssuedDuringPeriodValueRestrictedStockUnitsVested	1000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	835000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-391000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	309000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-65011000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	168767000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	5711000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1952000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	663000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-26551000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-18225000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-65011000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-26551000	USD
CY2021	us-gaap	Depreciation Depreciation	1014000	USD
CY2020	us-gaap	Depreciation Depreciation	922000	USD
CY2021	lidr	Common Stock Purchase Agreement Costs CommonStockPurchaseAgreementCosts	1583000	USD
CY2020	lidr	Common Stock Purchase Agreement Costs CommonStockPurchaseAgreementCosts	0	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1203000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	72000	USD
CY2021	lidr	Gain Loss On Embedded Derivative And Fair Value Adjustment Of Warrants GainLossOnEmbeddedDerivativeAndFairValueAdjustmentOfWarrants	223000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3655000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3811000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1483000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	193000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	557000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	484000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	5496000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1377000	USD
CY2021	lidr	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-538000	USD
CY2020	lidr	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	-496000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2258000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-290000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55703000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19689000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1021000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4036000	USD
CY2021	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	150525000	USD
CY2020	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151546000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4036000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	150000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	663000	USD
CY2021	lidr	Net Proceeds From Reverse Recapitalization Transaction NetProceedsFromReverseRecapitalizationTransaction	256811000	USD
CY2020	lidr	Net Proceeds From Reverse Recapitalization Transaction NetProceedsFromReverseRecapitalizationTransaction	0	USD
CY2021	lidr	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	52372000	USD
CY2020	lidr	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	0	USD
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	8045000	USD
CY2020	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	29990000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	10000000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2270000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13333000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	667000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	717000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	238000	USD
CY2021	lidr	Payments For Repurchase Of Stock Options PaymentsForRepurchaseOfStockOptions	1500000	USD
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020	lidr	Payments For Repurchase Of Stock Options PaymentsForRepurchaseOfStockOptions	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	207084000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32018000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-165000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8293000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16498000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8205000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16333000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16498000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	358000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	197000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	270000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13000	USD
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	62639000	USD
CY2020	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	USD
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	39095000	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021	lidr	Assumption Of Warrant Liability AssumptionOfWarrantLiability	268000	USD
CY2020	lidr	Assumption Of Warrant Liability AssumptionOfWarrantLiability	0	USD
CY2021	lidr	Reverse Recapitalization Transaction Costs Reclassified ReverseRecapitalizationTransactionCostsReclassified	289000	USD
CY2020	lidr	Reverse Recapitalization Transaction Costs Reclassified ReverseRecapitalizationTransactionCostsReclassified	0	USD
CY2021	lidr	Tax Withholding Accrued Share Based Payment Arrangement TaxWithholdingAccruedShareBasedPaymentArrangement	835000	USD
CY2020	lidr	Tax Withholding Accrued Share Based Payment Arrangement TaxWithholdingAccruedShareBasedPaymentArrangement	0	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	164007000	USD
CY2021	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain prior year amounts have been reclassified for consistency with the current year presentation. Specifically, restricted cash is now presented as a separate line item on the consolidated balance sheets and was previously included within other noncurrent assets. Inventory write-downs is now presented as a separate line item on the consolidated statements of cash flows and was previously included within changes in inventories, net. Amortization of debt issuance costs is now presented as amortization of debt discounts on the consolidated statements of cash flows. Noncash interest expense related to bank loans is now presented as amortization of debt issuance costs on the consolidated statements of cash flows.
CY2021	us-gaap	Use Of Estimates UseOfEstimates	The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include investments, embedded derivative and warrant liabilities (See Note 3), fair value of common stock, and stock-based compensation.
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2150000	USD
CY2020Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1223000	USD
	us-gaap	Payments For Rent PaymentsForRent	928000	USD
CY2020Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	1223000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:0.12pt;padding-left:22.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments which potentially subject the Company to concentration of credit risk consist primarily of cash, cash equivalents, and marketable securities, and accounts receivable. The Company places its cash and cash equivalents with major financial institutions, which management assesses to be of high credit quality, to limit the exposure of each investment. The Company’s marketable securities have investment grade ratings when purchased which mitigates risk. </span></div><div style="margin-bottom:0.12pt;padding-left:22.5pt"><span><br/></span></div><div style="margin-bottom:0.12pt;padding-left:22.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company’s accounts receivables are derived from customers located in the U.S., Europe, and Asia. The Company mitigates its credit risks by performing ongoing credit evaluations of its customers’ financial conditions. The Company generally does not require collateral.</span></div>The Company’s concentration of risk related to accounts receivable and accounts payable was determined by evaluating the number of customers and vendors accounting for 10% or more of accounts receivable (“AR”) and accounts payable (“AP”).
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1122000	USD
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	298000	USD
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2021	lidr	Standard Product Warranty Term StandardProductWarrantyTerm	P1Y
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q3	lidr	Common Stock And Preferred Stock Shares Authorized CommonStockAndPreferredStockSharesAuthorized	301000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	154404302	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	lidr	Common Stock Conversion Ratio CommonStockConversionRatio	1
CY2021Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q3	lidr	Class Of Warrant Or Right Period Exercisable ClassOfWarrantOrRightPeriodExercisable	P30D
CY2021Q3	lidr	Class Of Warrant Or Right Expiration Period ClassOfWarrantOrRightExpirationPeriod	P5Y
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2021Q3	us-gaap	Recapitalization Costs RecapitalizationCosts	2198000	USD
CY2021Q3	lidr	Gross Proceeds From Reverse Recapitalization Transaction GrossProceedsFromReverseRecapitalizationTransaction	256811000	USD
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2021Q3	lidr	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	36811000	USD
CY2021Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	220000000	USD
CY2021Q3	lidr	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	52661000	USD
CY2021Q3	lidr	Reverse Recapitalization Net ReverseRecapitalizationNet	204150000	USD
CY2021Q3	lidr	Stock Converted Reverse Recapitalization StockConvertedReverseRecapitalization	122509667	shares
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	110000	USD
CY2021	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	110000	USD
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues	1520000	USD
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1410000	USD
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	110000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14183000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15275000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2150000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1223000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16333000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16498000	USD
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1544000	USD
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1123000	USD
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2447000	USD
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1337000	USD
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	94000	USD
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	195000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	4085000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	2655000	USD
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	1203000	USD
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	72000	USD
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3980000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	549000	USD
CY2021Q4	lidr	Demonstration Units Current DemonstrationUnitsCurrent	224000	USD
CY2020Q4	lidr	Demonstration Units Current DemonstrationUnitsCurrent	0	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	847000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	847000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5051000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1396000	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	288000	USD
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	133000	USD
CY2020Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	27000	USD
CY2021Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	1376000	USD
CY2020Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	0	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1509000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	315000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	957000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	741000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3408000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	0	USD
CY2021Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1547000	USD
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	273000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	391000	USD
CY2021Q4	lidr	Accrued Purchases And Other Current AccruedPurchasesAndOtherCurrent	1947000	USD
CY2020Q4	lidr	Accrued Purchases And Other Current AccruedPurchasesAndOtherCurrent	1406000	USD
CY2021Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	275000	USD
CY2020Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	0	USD
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	605000	USD
CY2020Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	545000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8739000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3356000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	0	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7333000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6055000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	2204000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1190000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5129000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4865000	USD
CY2021	us-gaap	Depreciation Depreciation	1014000	USD
CY2020	us-gaap	Depreciation Depreciation	922000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	5577000	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2693000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2884000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	5577000	USD
CY2021	lidr	Common Stock Purchase Agreement Costs CommonStockPurchaseAgreementCosts	1583000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	725000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	97000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	752000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	830000	USD
CY2021	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	456000	USD
CY2020	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	0	USD
CY2020	lidr	Common Stock Purchase Agreement Costs CommonStockPurchaseAgreementCosts	0	USD
CY2021	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	4857000	USD
CY2020	lidr	Interest Expense And Other Nonoperating Expense InterestExpenseAndOtherNonoperatingExpense	1502000	USD
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2020	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	1214000	USD
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	16383725	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	155137237	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	155137237	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	lidr	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q3	lidr	Reverse Recapitalization Exchange Ratio ReverseRecapitalizationExchangeRatio	3.7208
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-65011000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-26551000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	109055894	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	102803202	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	109055894	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102803202	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.60
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.60
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44506507	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	48192300	shares
CY2021Q4	lidr	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	3	plan
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31618135	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M18D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	112548000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	498101	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.19
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	312037	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.48
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1026950	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.65
CY2021	lidr	Share Based Compensation Arrangement By Share Based Payment Award Options Repurchases In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRepurchasesInPeriod	542615	shares
CY2021	lidr	Share Based Compensation Arrangements By Share Based Payment Award Options Repurchases In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsRepurchasesInPeriodWeightedAverageExercisePrice	0.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	29238432	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.48
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	127345000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	27555673	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.48
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y3M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	120250000	USD
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	18615254	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.41
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	82475000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10018000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1952000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.95
CY2021Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	7637000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2287000	USD
CY2021	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2003000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3007000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1579000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3007000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1579000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	631000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2918000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	660000	USD
CY2019Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	950000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	570000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	450000	USD
CY2021	lidr	Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied	2828000	USD
CY2020	lidr	Contract With Customer Liability Increase For Invoice Issued On Performance Obligations Not Yet Satisfied ContractWithCustomerLiabilityIncreaseForInvoiceIssuedOnPerformanceObligationsNotYetSatisfied	160000	USD
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2918000	USD
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	660000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2287000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.043
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.334
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.118
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.035
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.003
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.011
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.015
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.012
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.025
CY2021	lidr	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	-0.039
CY2020	lidr	Effective Income Tax Rate Reconciliation Transaction Cost EffectiveIncomeTaxRateReconciliationTransactionCost	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.031
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	734000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.215
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	41856000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	17011000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4545000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	2810000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1040000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	51000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	178000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	40000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	464000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	48353000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	20376000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48353000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20376000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48353000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	20376000	USD
CY2020	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1942000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1210000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	938000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	40000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	14000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	431000	USD
CY2019Q4	us-gaap	Incentive From Lessor IncentiveFromLessor	3845000	USD
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1876000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	286000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1681000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1210000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2019	lidr	Operating Leases Number Of Extension Options OperatingLeasesNumberOfExtensionOptions	1	extension_option
CY2019Q4	lidr	Operating Leases Extension Term OperatingLeasesExtensionTerm	P5Y
CY2021Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	3637000	USD
CY2020Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	4175000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2393000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	2341000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	2412000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	2484000	USD
CY2021Q4	lidr	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	2340000	USD
CY2021Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	11970000	USD

Files In Submission

Name	View Source	Status
0001818644-22-000008-index-headers.html	Edgar Link	pending
0001818644-22-000008-index.html	Edgar Link	pending
0001818644-22-000008.txt	Edgar Link	pending
0001818644-22-000008-xbrl.zip	Edgar Link	pending
exhibit231consentofdeloitt.htm	Edgar Link	pending
exhibit311ceosection302cer.htm	Edgar Link	pending
exhibit312cfosection302cer.htm	Edgar Link	pending
exhibit321section906certif.htm	Edgar Link	pending
exhibit45descriptionofsecu.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lidr-20211231.htm	Edgar Link	pending
lidr-20211231.xsd	Edgar Link	pending
lidr-20211231_cal.xml	Edgar Link	unprocessable
lidr-20211231_def.xml	Edgar Link	unprocessable
lidr-20211231_g1.jpg	Edgar Link	pending
lidr-20211231_htm.xml	Edgar Link	completed
lidr-20211231_lab.xml	Edgar Link	unprocessable
lidr-20211231_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIDR
AEye, Inc. Stock $lidr

2021 Q4 Form 10-K Financial Statement

#000181864422000008 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIDR AEye, Inc. Stock $lidr

2021 Q4 Form 10-K Financial Statement

#000181864422000008 Filed on March 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIDR
AEye, Inc. Stock $lidr